FI87043C - Foerfarande foer framstaellning av ett stabilt farmaceutiskt preparat som innehaoller nikorandil - Google Patents

Foerfarande foer framstaellning av ett stabilt farmaceutiskt preparat som innehaoller nikorandil Download PDF

Info

Publication number
FI87043C
FI87043C FI870131A FI870131A FI87043C FI 87043 C FI87043 C FI 87043C FI 870131 A FI870131 A FI 870131A FI 870131 A FI870131 A FI 870131A FI 87043 C FI87043 C FI 87043C
Authority
FI
Finland
Prior art keywords
acid
nicorandil
tablets
tablet
mixture
Prior art date
Application number
FI870131A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI870131A (fi
FI870131A0 (fi
FI87043B (fi
Inventor
Yoshimitsu Iida
Shuji Sumida
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26342067&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI87043(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of FI870131A0 publication Critical patent/FI870131A0/fi
Publication of FI870131A publication Critical patent/FI870131A/fi
Application granted granted Critical
Publication of FI87043B publication Critical patent/FI87043B/fi
Publication of FI87043C publication Critical patent/FI87043C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FI870131A 1986-01-17 1987-01-14 Foerfarande foer framstaellning av ett stabilt farmaceutiskt preparat som innehaoller nikorandil FI87043C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP772286 1986-01-17
JP772286 1986-01-17
JP6185686 1986-03-19
JP6185686 1986-03-19

Publications (4)

Publication Number Publication Date
FI870131A0 FI870131A0 (fi) 1987-01-14
FI870131A FI870131A (fi) 1987-07-18
FI87043B FI87043B (fi) 1992-08-14
FI87043C true FI87043C (fi) 1992-11-25

Family

ID=26342067

Family Applications (1)

Application Number Title Priority Date Filing Date
FI870131A FI87043C (fi) 1986-01-17 1987-01-14 Foerfarande foer framstaellning av ett stabilt farmaceutiskt preparat som innehaoller nikorandil

Country Status (21)

Country Link
US (1) US4822808A (no)
EP (1) EP0230932B1 (no)
KR (1) KR940000232B1 (no)
CN (1) CN1009525B (no)
AR (1) AR241514A1 (no)
AU (1) AU591958B2 (no)
CA (1) CA1285486C (no)
CS (1) CS276587B6 (no)
DE (1) DE3769662D1 (no)
DK (1) DK174918B1 (no)
EG (1) EG18088A (no)
ES (1) ES2054623T3 (no)
FI (1) FI87043C (no)
GR (1) GR3002288T3 (no)
HK (1) HK66193A (no)
HU (1) HU196705B (no)
MX (1) MX167912B (no)
NO (1) NO173590C (no)
NZ (1) NZ218917A (no)
PT (1) PT84124B (no)
SG (1) SG64893G (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5637322A (en) * 1992-11-06 1997-06-10 Japan Tobacco Inc. Method for producing composition for solid medicine
US6218411B1 (en) * 1997-08-08 2001-04-17 Chugai Seiyaku Kabushiki Kaisha Therapeutics for diabetic complications
IT1293835B1 (it) * 1997-08-08 1999-03-10 Foscama Biomed Chim Farma Composizioni farmaceutiche orali in forma solida a cessione modulata contenenti nicorandil e procedimento per la loro preparazione
JP5048177B2 (ja) * 1998-05-15 2012-10-17 中外製薬株式会社 放出制御製剤
WO2000067754A1 (en) 1999-05-12 2000-11-16 Nitromed, Inc. Nitrosated and nitrosylated potassium channel activators, compositions and methods of use
TWI324074B (en) * 2001-10-09 2010-05-01 Bristol Myers Squibb Co Flashmelt oral dosage formulation
FR2872705B1 (fr) * 2004-07-08 2008-07-18 Aventis Pharma Sa Compositions contenant du nicorandil, procede de preparation et utilisation
WO2008112227A1 (en) * 2007-03-12 2008-09-18 Reliant Pharmaceuticals, Inc. Treatment with nicorandil and omega-3 fatty acids, and a combination product thereof
SI2098249T1 (sl) * 2008-03-05 2013-02-28 Rivopharm Sa Nosilci nikorandila s povečano stabilnostjo
KR20100007082A (ko) * 2008-07-11 2010-01-22 주식회사 엘지생명과학 니코란딜을 포함하는 서방성 제제
JPWO2010018866A1 (ja) * 2008-08-14 2012-01-26 杏林製薬株式会社 安定化された医薬組成物
WO2014174846A1 (ja) 2013-04-25 2014-10-30 杏林製薬株式会社 固形医薬組成物
CN110123749B (zh) * 2019-06-03 2022-01-25 太阳升(亳州)生物医药科技有限公司 尼可地尔脂微球制剂及其制备方法
CN111574441B (zh) * 2020-05-26 2021-12-31 中国科学院上海药物研究所 一种尼可地尔与水杨酸的共晶及其制备方法和应用
CN115429763B (zh) * 2021-06-02 2024-01-02 北京四环科宝制药股份有限公司 尼可地尔片剂及其制备方法
CN114732792A (zh) * 2022-03-25 2022-07-12 北京诺康达医药科技股份有限公司 一种尼可地尔口腔崩解片及其制备方法
CN115317456A (zh) * 2022-08-17 2022-11-11 北京科源创欣科技有限公司 一种尼可地尔片组合物及其制备方法
CN115282123B (zh) * 2022-09-13 2023-11-03 南京比逊医药科技有限公司 一种稳定的尼可地尔制剂的制备方法
CN117547534B (zh) * 2023-11-10 2024-07-12 江南大学 尼可地尔缓释制剂及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3168438A (en) * 1962-08-09 1965-02-02 Synergistics Inc Vasodilation by nitric acid ester derivatives of nicotinic acid
US3332848A (en) * 1963-07-10 1967-07-25 Hoffmann La Roche Microcrystalline cellulose with starch in niacinamide ascorbic acid tablet granulations
US4200640A (en) * 1976-04-02 1980-04-29 Chugai Seiyaku Kabushiki Kaisha Nitric ester of N-(2-hydroxyethyl)nicotinamide and pharmaceutical use
JPS599539B2 (ja) * 1979-11-13 1984-03-03 日本化薬株式会社 ニトログリセリン水溶液及びその製造法
US4490377A (en) * 1980-07-29 1984-12-25 Syntex (U.S.A.) Inc. Acid stabilized compositions of thieno-pyridine derived compounds
JPS57145659A (en) * 1981-03-06 1982-09-08 Chugai Pharmaceutical Co Ltd Production of tablet
US4382091A (en) * 1981-04-30 1983-05-03 Syntex (U.S.A.) Inc. Stabilization of 1-substituted imidazole derivatives in talc
JPS5839618A (ja) * 1981-09-04 1983-03-08 Chugai Pharmaceut Co Ltd 持続性積層錠剤
DE3244178A1 (de) * 1982-11-30 1984-05-30 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung sowie ihre verwendung in arzneimitteln
DE3421468A1 (de) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim Lipidnanopellets als traegersystem fuer arzneimittel zur peroralen anwendung
JPH0653658B2 (ja) * 1984-12-17 1994-07-20 中外製薬株式会社 安定な錠剤の製造法
US5188840A (en) * 1985-09-26 1993-02-23 Chugai Seiyaku Kabushiki Kaisha Slow-release pharmaceutical agent

Also Published As

Publication number Publication date
NZ218917A (en) 1989-10-27
HUT44435A (en) 1988-03-28
EP0230932B1 (en) 1991-05-02
EG18088A (en) 1992-08-30
MX167912B (es) 1993-04-22
NO870212D0 (no) 1987-01-19
AU6764887A (en) 1987-07-23
SG64893G (en) 1993-08-06
KR870006894A (ko) 1987-08-13
EP0230932A2 (en) 1987-08-05
ES2054623T3 (es) 1994-08-16
NO173590B (no) 1993-09-27
FI870131A (fi) 1987-07-18
KR940000232B1 (ko) 1994-01-12
GR3002288T3 (en) 1992-12-30
DK174918B1 (da) 2004-02-23
PT84124B (pt) 1989-02-28
HU196705B (en) 1989-01-30
CN1009525B (zh) 1990-09-12
PT84124A (en) 1987-02-01
CN87100285A (zh) 1987-08-19
US4822808A (en) 1989-04-18
CS276587B6 (en) 1992-07-15
FI870131A0 (fi) 1987-01-14
NO870212L (no) 1987-07-20
FI87043B (fi) 1992-08-14
EP0230932A3 (en) 1987-12-09
CS8700282A2 (en) 1991-07-16
AU591958B2 (en) 1989-12-21
DK19187A (da) 1987-07-18
AR241514A1 (es) 1992-08-31
HK66193A (en) 1993-07-16
DK19187D0 (da) 1987-01-15
NO173590C (no) 1994-01-05
CA1285486C (en) 1991-07-02
DE3769662D1 (de) 1991-06-06

Similar Documents

Publication Publication Date Title
FI87043C (fi) Foerfarande foer framstaellning av ett stabilt farmaceutiskt preparat som innehaoller nikorandil
DK167171B1 (da) Fremgangsmaade til fremstilling af et stabilt nicorandilholdigt farmaceutisk praeparat
SU1743332A3 (ru) Способ получени таблеток
US3082154A (en) Improved free-flowing coated antimalarial salts in particulate form
US4786507A (en) Long shelf life tablet containing hydrolysis prone active ingredient
US6194005B1 (en) Method for preparing a pharmaceutical composition with modified release of the active principle, comprising a matrix
EP0219161B1 (en) Process for the preparation of stabilized isosorbide-5-mononitrate tablets, being also of sustained release, and formulations thus obtained
IE58834B1 (en) Novel galenic retard form
US6291462B1 (en) Oral medicinal preparations with reproducible release of the active ingredient gatifloxacin or its pharmaceutically suitable salts or hydrates
EP3449912A1 (en) Orally disintegrating tablet
EP1256338B1 (en) A process for the preparation of direct tabletting formulations and aids
BR112015003116B1 (pt) Preparação farmacêutica sólida contendo levotiroxina
JP2512302B2 (ja) ニコランジル安定化製剤の製造方法
EP2379057B1 (en) Phenylephrine formulations with improved stability
KR20160002177A (ko) 오셀타미비어 유리염기를 포함하는 약학 조성물
US20100021393A1 (en) Pharmaceutical Compositions Comprising Effervescent Agents and Fenofibrate
CA2450001A1 (en) Stable pharmaceutical compositions containing pravastatin
AU681980B2 (en) Preparation of fusidic acid tablets
KR102015516B1 (ko) 안정성이 개선된 습식과립 정제 및 이의 제조방법
KR20160140567A (ko) 오셀타미비어 유리염기를 포함하는 약학 조성물
EP1872777A1 (en) Pharmaceutical composition comprising tetrahydrolipstatin
US20020142037A1 (en) Process for the manufacture of a pharmaceutical composition with modified release of active principle comprising a matrix
CN115282123A (zh) 一种稳定的尼可地尔制剂的制备方法
EA006157B1 (ru) Лекарственная форма силимарина и способ ее получения
CS251847B1 (cs) Potahované tablety s obsahem 2,5 mg nebo 5,0 mg trinitrátu glycerolu a jeho řízeným uvolňováním

Legal Events

Date Code Title Description
FG Patent granted

Owner name: CHUGAI SEIYAKU KABUSHIKI KAISHA

MA Patent expired